METHOD AND COMPOSITIONS FOR THE IN VITRO DIAGNOSIS OF ILLNESSES DUE TO LYSOZOMIAL DEFICIENCIES OR CHROMOSOMAL ABERRATIONS, PARTICULARLY MUSCULAR DISTROPHY OR CYSTIC FIBROSIS

Process for in-vitro diagnosis of the potentiality or of the existence of cystic fibrosis, of muscular dystrophy or of a chromosome anomaly. It consists in placing a culture of cells originating from the individual or embryo being studied in contact with a cocktail comprising especially heparin, a h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HOSLI, PETER, VOGT, ESTHER
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Process for in-vitro diagnosis of the potentiality or of the existence of cystic fibrosis, of muscular dystrophy or of a chromosome anomaly. It consists in placing a culture of cells originating from the individual or embryo being studied in contact with a cocktail comprising especially heparin, a human gamma -globulin, an E2 prostaglandin, theophylline and cycloheximide, in proportions adjusted so as not appreciably to affect the development of the healthy cells but to result in the death of the said cells when they originate from an individual affected by one of the abovementioned diseases.